Clinical Trials · NCT06003465
A Research Study Looking at Similarity Between LY3437943 Versions for Different Injection Devices
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 57
- Start date
- Aug 2023
- Locations
- 3 sites, United States
- Primary endpoint
- Pharmacokinetics (PK): Maximum Concentration (Cmax) of LY3437943